Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 14, 2014; 20(34): 12226-12232
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12226
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12226
Variable | HR | Coef. | P value | 95%CI for HR | ||
Model 1 (n = 83) Stratified by chemotherapy status | ||||||
High MBSS | 2.63 | 0.969 | 0.001 | 1.49 | 4.67 | |
Age | 1.03 | 0.030 | 0.027 | 1.00 | 1.06 | |
Tumor size (cm) | 1.21 | 0.189 | 0.101 | 0.96 | 1.51 | |
Model 2 (n = 74) Interaction between MBSS group and chemotherapy status | ||||||
Low MBSS | Chemotherapy | 1.29 | 0.256 | 0.625 | 0.46 | 3.61 |
Age | 1.03 | 0.032 | 0.024 | 1.00 | 1.06 | |
Tumor size (cm) | 1.16 | 0.149 | 0.190 | 0.93 | 1.45 | |
No Chemotherapy | High MBSS | 4.14 | 1.421 | 0.007 | 1.48 | 11.64 |
Chemotherapy | High MBSS | 2.11 | 0.740 | 0.033 | 1.06 | 4.17 |
- Citation: Jamal MH, Doi SAR, Moser AJ, Dumitra S, Khalil JA, Simoneau E, Chaudhury P, Onitilo AA, Metrakos P, Barkun JS. McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinoma. World J Gastroenterol 2014; 20(34): 12226-12232
- URL: https://www.wjgnet.com/1007-9327/full/v20/i34/12226.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i34.12226